Clinical and Histopathological Spectrum of Toxic Erythema of Chemotherapy in Patients Who Have Undergone Allogenic Hematopoietic Cell Transplantation
ConclusionThe diagnosis of TEC should be considered after a correlation of clinical and histological findings in conjunction with a timeline of chemotherapy administration. TEC is a clinical diagnosis that is supported by pathological confirmation. Suggested criteria for the diagnosis of TEC may be helpful to dermatologists and clinicians when caring for these patients.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Dermatology | Dermatomyositis | Hematology | Pathology | Skin | Stem Cell Therapy | Stem Cells | Toxicology | Transplants